Vouchers for Improving Transplant Access to Lifestyle Nutrition - Kidney Transplant (VITAL-KT)

March 9, 2026 updated by: University of California, San Francisco

Improving Dietary Quality and Health Outcomes: A Fruit and Vegetable Voucher Program for Kidney Transplant Patients With Food Insecurity.

This study evaluates the effect of a six-month fruit and vegetable voucher program on satisfaction, dietary quality, and health outcomes among pediatric and young adult kidney transplant recipients experiencing food insecurity.

Study Overview

Detailed Description

This is a single-arm, prospective interventional study enrolling 18 participants aged 6 to 25 years who have undergone kidney transplantation and screened positive for food insecurity within the past six months.

Participants will receive monthly fruit and vegetable vouchers for six months, distributed via Electronic Benefit Transfer (EBT) cards. The EBT cards, managed by an external partner, will be automatically reloaded monthly and be redeemable at participating retailers.

Data collection will include participant-reported satisfaction surveys post-intervention, food security and dietary quality assessments at baseline and study end, biophysical outcomes (BMI, blood pressure) from routine clinical care, laboratory markers related to kidney and nutritional health (serum potassium, phosphorus, magnesium, albumin, bicarbonate, fasting glucose or HbA1c, and creatinine/GFR), tacrolimus variability to serve as a proxy for medication adherence.

No extra clinical visits or lab draws beyond standard care are required. The findings aim to inform future strategies to address food insecurity in transplant populations.

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Francisco, California, United States, 94107
        • UCSF Benioff Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age: Children and young adults aged 2 to 25 years who have received a kidney transplant.
  • Food Insecurity: Patients who have screened positive for food insecurity (FI) within the past six months, based on the Hunger Vital Sign
  • Patients who are currently receiving care at the transplant center and whose caregivers (if the patient is less than 18 years of age) are willing to participate in the intervention.
  • Caregivers of non-adult patients

Exclusion Criteria:

  • Patient being on a diet consisting of only total parenteral nutrition or tube feeds.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Food Voucher Intervention Arm
Participants in this arm will receive monthly food vouchers in the form of an Electronic Benefit Transfer (EBT) card, which will be mailed to their home and refilled each month for a total of 6 months. The EBT cards are provided and managed by an external community-based organization in partnership with the research team. The voucher amount is intended to supplement household food purchases and reduce food insecurity. The intervention targets pediatric and young adult kidney transplant recipients who have screened positive for food insecurity within the past 6 months. The participants will use the vouchers, and both pre- and post-intervention surveys will be administered to assess food security status and dietary quality. This supportive care intervention is designed to enhance nutritional support and promote stability during the post-transplant period.
Participants will receive a monthly food voucher in the form of an Electronic Benefit Transfer (EBT) card, mailed to their home and refilled each month for 6 months. The EBT cards are provided and managed by an external community-based organization in partnership with the research team. The intervention is designed to supplement household food purchases, reduce food insecurity, and support nutritional well-being among pediatric and young adult kidney transplant recipients who have recently screened positive for food insecurity. Pre- and post-intervention surveys will be used to assess food security status and dietary quality.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant Satisfaction Difference
Time Frame: From enrollment to the end of treatment at 6 months
Participant satisfaction with the food voucher program assessed through a survey administered by the end of the 6-month intervention period. This survey will evaluate participants' overall satisfaction with the EBT card, including the perceived impact on food security, ease of use, and the perceived value of the program.
From enrollment to the end of treatment at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants who screen positively for food insecurity
Time Frame: From enrollment to the end of treatment at 6 months
Food security status will be assessed using a validated food security questionnaire at baseline and post-intervention. This measure will capture changes in household food access and adequacy as a result of the intervention.
From enrollment to the end of treatment at 6 months
Dietary Quality Difference
Time Frame: From enrollment to the end of treatment at 6 months
Dietary quality will be assessed using self-reported dietary intake questions included in the pre- and post-intervention surveys. This measure will provide insight into any changes in the participants' food choices and nutritional habits due to the intervention, focusing on the amount of monthly fruit and vegetable intake.
From enrollment to the end of treatment at 6 months
Number of participants who screen positively for nutrition insecurity
Time Frame: From enrollment to the end of treatment at 6 months
Nutrition security status will be assessed using validated nutrition security questions within the pre- and post-surveys.
From enrollment to the end of treatment at 6 months
Body mass index (BMI) Difference
Time Frame: At baseline and 6 months.
Weight and height will be combined to report BMI in kg/m^2.
At baseline and 6 months.
Blood pressure difference
Time Frame: From enrollment to the end of treatment at 6 months
Difference of systolic and diastolic blood pressure as measured in mmHg.
From enrollment to the end of treatment at 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Serum Creatinine and GFR difference
Time Frame: From enrollment to the end of treatment at 6 months
Kidney function assessed through serum creatinine and estimated GFR.
From enrollment to the end of treatment at 6 months
Tacrolimus Variability (Proxy for Medication Adherence)
Time Frame: From enrollment to the end of treatment at 6 months
Tacrolimus variability will be assessed by measuring fluctuations in tacrolimus blood levels during the study period. Variability in tacrolimus levels can serve as a proxy for medication adherence in pediatric kidney transplant recipients. Stable tacrolimus levels typically reflect better adherence to prescribed medication regimens, and variability can indicate missed doses or inconsistent adherence.
From enrollment to the end of treatment at 6 months
HbA1c difference
Time Frame: From enrollment to the end of treatment at 6 months
Glycemic control assessed by difference of HbA1c percent (%) values
From enrollment to the end of treatment at 6 months
Serum potassium difference
Time Frame: From enrollment to the end of treatment at 6 months
Difference on serum potassium as measured in mEq/L
From enrollment to the end of treatment at 6 months
Serum magnesium difference
Time Frame: From enrollment to the end of treatment at 6 months
Serum magnesium difference as measured in mg/dL.
From enrollment to the end of treatment at 6 months
Serum bicarbonate difference
Time Frame: From enrollment to the end of treatment at 6 months
Serum bicarbonate difference measured in CO2 content in blood in mEq/L
From enrollment to the end of treatment at 6 months
Changes in medications
Time Frame: From enrollment to the end of treatment at 6 months
Changes in medications such as blood rpessure mendications and supplementation
From enrollment to the end of treatment at 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eva Glenn Lecea, MD, University of California, San Francisco

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2025

Primary Completion (Actual)

January 20, 2026

Study Completion (Actual)

January 20, 2026

Study Registration Dates

First Submitted

April 21, 2025

First Submitted That Met QC Criteria

April 29, 2025

First Posted (Actual)

May 1, 2025

Study Record Updates

Last Update Posted (Actual)

March 11, 2026

Last Update Submitted That Met QC Criteria

March 9, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 25-43473
  • P0580734 (Other Grant/Funding Number: Agency of Healthcare Research and Quality)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Food Insecurity

Clinical Trials on Fruit and Vegetable Voucher Support Program

Subscribe